Nan Chen,MD

Quick facts

Marketed products

• RAS 2410 · Oncology
  RAS 2410 is a selective inhibitor of the RAS pathway.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Nan Chen,MD portfolio CI brief
• Nan Chen,MD pipeline updates RSS